Skip to main content

Table 1 Clinical and imaging characteristics of included patients (N = 62)

From: Tumor conspicuity significantly correlates with postoperative recurrence in patients with pancreatic cancer: a retrospective observational study

 

N = 62

Age (yrs, mean ± SD)

65.97(±11.66)

Male (n,%)

35 (56.5)

Presence of diabetes mellitus (DM)

24 (38.7)

Charlson age-comorbidity index (CCI, median, range)

5 (2–9)

Preoperative CA19–9 (U/mL, median, range)

133.1 (2–12,000)

Postoperative CA19–9 (U/mL, median, range)

34.4 (0.39–12,000)

Interval between initial imaging and operation date (mo., median, range)

0.5 (0.5–20)

Adjuvant chemotherapy (n,%)

46 (74.2)

Location of tumor

 Head/ Body/Tail

38/12/12

Vascular invasion

38 (61.3)

 Celiac trunk/SMA/CHA

7 (11.3)

 PV/SMV/portomesenteric confluence

16 (25.8)

 Others: IVC, left renal vein

3 (4.8)

Conspicuity score > 2

25 (40.3)

Radiologic tumor size (cm)

2.78(±0.87)

Resectability

 Resectable/borderline resectable/unresectable

37/23/2

 Presence of obstructive pancreatitis (n, %)

50 (80.6)

 Presence of double primary cancer (n,%)

6 (9.6)

  1. SD standard deviation, SMA superior mesenteric artery, SMV superior mesenteric vein, CHA common hepatic artery, PV portal vein, IVC inferior vena cava